Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016:2016:9051426.
doi: 10.1155/2016/9051426. Epub 2016 Aug 9.

Experimental Diabetes Mellitus in Different Animal Models

Amin Al-Awar  1 , Krisztina Kupai  1 , Médea Veszelka  1 , Gergő Szűcs  1 , Zouhair Attieh  2 , Zsolt Murlasits  3 , Szilvia Török  1 , Anikó Pósa  1 , Csaba Varga  1
Affiliations
Review

Experimental Diabetes Mellitus in Different Animal Models

Amin Al-Awar et al. J Diabetes Res. 2016.

Abstract

Animal models have historically played a critical role in the exploration and characterization of disease pathophysiology and target identification and in the evaluation of novel therapeutic agents and treatments in vivo. Diabetes mellitus disease, commonly known as diabetes, is a group of metabolic disorders characterized by high blood glucose levels for a prolonged time. To avoid late complications of diabetes and related costs, primary prevention and early treatment are therefore necessary. Due to its chronic symptoms, new treatment strategies need to be developed, because of the limited effectiveness of the current therapies. We overviewed the pathophysiological features of diabetes in relation to its complications in type 1 and type 2 mice along with rat models, including Zucker Diabetic Fatty (ZDF) rats, BB rats, LEW 1AR1/-iddm rats, Goto-Kakizaki rats, chemically induced diabetic models, and Nonobese Diabetic mouse, and Akita mice model. The advantages and disadvantages that these models comprise were also addressed in this review. This paper briefly reviews the wide pathophysiological and molecular mechanisms associated with type 1 and type 2 diabetes, particularly focusing on the challenges associated with the evaluation and predictive validation of these models as ideal animal models for preclinical assessments and discovering new drugs and therapeutic agents for translational application in humans.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Summary of animal models of diabetes mellitus.
Figure 2
Figure 2
The mechanism of action of streptozotocin (STZ) in β cells.
Figure 3
Figure 3
The main pathological effects of alloxan.
Figure 4
Figure 4
Akita mice.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Danaei G., Finucane M. M., Lu Y., et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. The Lancet. 2011;378(9785):31–40. doi: 10.1016/s0140-6736(11)60679-x. - DOI - PubMed
    1. Bluestone J. A., Herold K., Eisenbarth G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature. 2010;464(7293):1293–1300. doi: 10.1038/nature08933. - DOI - PMC - PubMed
    1. Todd J. A. Etiology of type 1 diabetes. Immunity. 2010;32(4):457–467. doi: 10.1016/j.immuni.2010.04.001. - DOI - PubMed
    1. Hyttinen V., Kaprio J., Kinnunen L., Koskenvuo M., Tuomilehto J. Genetic liability of type 1 diabetes and the onset age among 22, 650 young Finnish twin pairs: a nationwide follow-up study. Diabetes. 2003;52(4):1052–1055. doi: 10.2337/diabetes.52.4.1052. - DOI - PubMed
    1. Tao B., Pietropaolo M., Atkinson M., Schatz D., Taylor D. Estimating the cost of type 1 diabetes in the U.S.: a propensity score matching method. PLoS ONE. 2010;5(7) doi: 10.1371/journal.pone.0011501.e11501 - DOI - PMC - PubMed

MeSH terms